Versant Capital Management, Inc - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2019$0–840.0%0.00%–
Q2 2019$0
-100.0%
84
-78.9%
0.00%
-100.0%
Q3 2016$1,0000.0%3990.0%0.00%0.0%
Q2 2016$1,000
-50.0%
399
-35.2%
0.00%0.0%
Q1 2016$2,000
-60.0%
616
-62.0%
0.00%
-66.7%
Q4 2015$5,000–1,623–0.00%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders